Kansas Agricultural Experiment Station Research Reports
Volume 0
Issue 2 Dairy Research (1984-2014)

Article 281

2003

Leptospirosis: A new perspective on an old disease
Jerry Olson

Follow this and additional works at: https://newprairiepress.org/kaesrr
Part of the Dairy Science Commons

Recommended Citation
Olson, Jerry (2003) "Leptospirosis: A new perspective on an old disease," Kansas Agricultural Experiment
Station Research Reports: Vol. 0: Iss. 2. https://doi.org/10.4148/2378-5977.3206
This report is brought to you for free and open access by New
Prairie Press. It has been accepted for inclusion in Kansas
Agricultural Experiment Station Research Reports by an
authorized administrator of New Prairie Press. Copyright 2003
Kansas State University Agricultural Experiment Station and
Cooperative Extension Service. Contents of this publication
may be freely reproduced for educational purposes. All other
rights reserved. Brand names appearing in this publication are
for product identification purposes only. No endorsement is
intended, nor is criticism implied of similar products not
mentioned. K-State Research and Extension is an equal
opportunity provider and employer.

Leptospirosis: A new perspective on an old disease
Abstract
Disease causing Leptospira can be placed in one of two broad categories for common domesticated
mammals: They are either hostadapted or incidental strains. The four incidental serovars of Leptospira
that are pathogenic to cattle are: L. pomona, L. grippotyphosa, L. canicola and L. icterhemmorhagiae.
They are transmitted to cattle from other carrier animals that act as hosts for these strains. The strains
are found in chronically infected rats, dogs, deer, or even pigs and are transmitted to cattle though urinecontaminated water. When the incidental strains of Leptospira are introduced into an unvaccinated,
susceptible herd of cattle, they commonly cause an outbreak of abortions in the mid- to late-term
pregnant cows. Commercial five-way Leptospiral vaccines are effective in preventing the abortion storms
associated with the incidental strains of Leptospira, but ineffective to the most common serovar found in
cattle (hardjo-bovis). Pfizer Animal Health recently received USDA approval to market the first effective L.
hardjo vaccine, known as Spirovac®, in the United States.; Dairy Day, 2003, Kansas State University,
Manhattan, KS, 2003;
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LEPTOSPIROSIS: A NEW PERSPECTIVE ON AN OLD DISEASE
Jerry D. Olson, DVM, MS, DACT

rovar hardjo (Type: hardjo-bovis), commonly
referred to as L. hardjo. The primary source of
L. hardjo-bovis for uninfected cattle is the
urine of chronically infected cattle. Once cattle are infected, they may shed the organism in
the urine for weeks or years. The primary
manifestation of hardjo-bovis in cattle is a
mild disease characterized primarily by low
conception rates, but may cause embryonic
deaths, abortions, and stillbirths.

Summary
Disease causing Leptospira can be placed
in one of two broad categories for common
domesticated mammals: They are either hostadapted or incidental strains. The four incidental serovars of Leptospira that are pathogenic
to cattle are: L. pomona, L. grippotyphosa, L.
canicola and L. icterhemmorhagiae. They are
transmitted to cattle from other carrier animals
that act as hosts for these strains. The strains
are found in chronically infected rats, dogs,
deer, or even pigs and are transmitted to cattle
though urine-contaminated water. When the
incidental strains of Leptospira are introduced
into an unvaccinated, susceptible herd of cattle, they commonly cause an outbreak of abortions in the mid- to late-term pregnant cows.
Commercial five-way Leptospiral vaccines are
effective in preventing the abortion storms
associated with the incidental strains of Leptospira, but ineffective to the most common serovar found in cattle (hardjo-bovis). Pfizer
Animal Health recently received USDA approval to market the first effective L. hardjo
vaccine, known as Spirovac®, in the United
States.

The first report indicating that the current
five-way leptospiral vaccines were ineffective
in providing protection against infections from
L. hardjo was published by Bolin in 1989.
Bolin had three groups of experimental animals: 1) an unvaccinated control group, 2) a
group of cows that was vaccinated once, and
3) a group of cows that was vaccinated twice.
All three experimental groups of cattle were
bred after control or treatment vaccinations,
and at midgestation they were experimentally
challenged with a virulent strain of L. hardjo.
All control cows and 13 of 16 vaccinated
cows became infected and shed L. hardjo in
the urine. The percentage of urine specimens
that contained Leptospira organisms was reduced in the experimental groups of vaccinated cattle compared to controls (79% vs.
11%, respectively). The calves from these
cows were sacrificed after birth and Leptospira organisms were identified in the kidneys
of 17 of 19 of the calves from control and
vaccinated cows. The authors concluded the
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Background
The host-adapted strain for cattle in the
United States is Leptospira borgpetersenii se-
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in dairy cattle. Within herds that were positive
of L. hardjo, it is estimated that 30% of the
cows were infected.

current five-way vaccines failed to prevent
renal-shedding of L. hardjo in the urine of the
cows and failed to prevent fetal infection with
the organism in the fetal kidneys.

Low conception rates in dairy herds can be
caused by numerous factors. When a dairy
herd experiences low conception rates, L.
hardjo should be considered in the differential
diagnosis. Urine samples should be collected
and sent to a diagnostic laboratory familiar
with performing either the fluorescent antibody or PCR tests that allow identification of
the organism in urine. Another characteristic
observed in herds with endemic L. hardjo is a
lower pregnancy rate in first-lactation cows in
the majority of estrous cycles after the end of
the voluntary waiting period when compared
to second or greater lactating cows. Normally
first lactation cows are more fertile and have
greater pregnancy rates than older cows.

In a later study Bolin demonstrated that
vaccination with L. hardjo vaccine altered the
serological response to the disease so the titers
of L. hardjo-challenged cattle that were vaccinated were no different than that of nonchallenged vaccinated cattle. Nonvaccinated
cattle that were challenged with L. hardjo developed titers that were diagnostic of L.
hardjo infections. The conclusion was that the
vaccine not only provided little to no protection to cattle for the prevention of renal infection of dams or fetal infection, but it made serological diagnosis of L. hardjo, the traditional
method for diagnosing the disease, impossible.
The only positive factor about the existing
vaccines with respect to L. hardjo is that they
may reduce the duration of renal shedding in
cows. It was not until state-supported diagnostic laboratories began to offer fluorescent antibody and PCR tests for identification of the
organism in cattle urine in the late 1990s that
disease diagnosis became practical.

Pfizer Animal Health recently received
USDA approval to market in the United States
the first effective L. hardjo vaccine, known as
Spirovac®. The vaccine has been available to
dairy producers in other areas of the world for
several years. Immunizing dairy animals consists of initial administration of two doses of
vaccine 4 to 6 weeks apart, followed by annual vaccination. Some producers have chosen
to vaccinate cows as they go through the dry
period, whereas others have chosen to vaccinate the entire herd at one time. Initial reports
from herds that have been diagnosed with L.
hardjo and have been vaccinated look promising.

Recent Findings
A recent survey was conducted to determine the incidence of L. hardjo infections in
U.S. dairy herds. Eleven herds were selected
in each of four regions of the country: Southeast, Midwest, Northwest, and West. Of the 44
herds in the survey, 57% were infected with L.
hardjo, the most common form of Leptospira
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